Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 7, 2003, Pages 2954-2958

  Holzer, Mike P ^a   Solomon, Kerry D ^a   Vroman, David T ^a   Sandoval, Helga P ^a   Margaron, Philippe ^b   Kasper, Terrance J ^a   Crosson, Craig E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b QLT Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CILIARY BODY; CORNEA; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; DRUG EFFICACY; HISTOLOGY; INTRAOCULAR PRESSURE; IRIS; LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTERIOR EYE SEGMENT; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENOUS; LASERS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RABBITS;

EID: 0038238254     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0572     Document Type: Article

References (16)

1. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245-269.
2. Epstein RJ, Stulting RD, Hendricks RL, Harris DM. Corneal neovascularization: pathogenesis and inhibition. Cornea. 1987;6:250-257.
3. Kobayashi N, Kabuyama Y, Sasaki S, et al. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002;21:62-67.
4. Joussen AM, Beecken WD, Moromizato Y, et al. Inhibition of inflammatory corneal angiogenesis by TNP-470. Invest Ophthalmol Vis Sci. 2001;42:2510-2516.
5. Epstein RJ, Hendricks RL, Harris DM. Photodynamic therapy for corneal neovascularization. Cornea. 1991;10:424-432.
6. Schmidt-Erfurth U, Hasan T, Schomacker K, et al. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med. 1995;17:178-188.
7. Gohto Y, Obana A, Kaneda K, et al. Accumulation of photosensitizer ATX-S10 (Na) in experimental corneal neovascularization. Jpn J Ophthalmol. 2000;44:348-353.
8. Gohto Y, Obana A, Kanai M, et al. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na). Ophthalmic Surg Lasers. 2000;31:55-60.
9. Primbs GB, Casey R, Wamser K, et al. Photodynamic therapy for corneal neovascularization. Ophthalmic Surg Lasers. 1998;29:832-838.
10. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation. Eye. 2001;15:407-412.
11. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology. 2001;108:841-852.
12. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report: treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Arch Ophthalmol. 1999;117:1329-1345.
13. Donnenfeld ED, Ingraham H, Perry HD, et al. Contact lens-related deep stromal intracorneal hemorrhage. Ophthalmology. 1991;98:1793-1796.
14. Maziere JC, Santus R, Morliere P, et al. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol. 1990;6:61-68.
15. Chang IL, Elner G, Yue YJ, et al. Expression of modified low-density lipoprotein receptors by trabecular meshwork cells. Curr Eye Res. 1991;10:1101-1112.
16. Elner SG, Elner VM, Pavilack MA, et al. Human and monkey corneal endothelium expression of low-density lipoprotein receptors. Am J Ophthalmol. 1991;111:84-91.